A successful Alzheimer's drug has been viewed as the holy grail in biotech, as it would combat a de…

The decision to approve Aduhelm has raised concerns and led three advisors to resign. The agency's …

The Food and Drug Administration approved Biogen's Alzheimer's disease treatment even though outsid…

Stocks closed sharply higher after hitting intraday records on positive vaccine data from Pfizer an…

News about the COVID-19 vaccine developed by Pfizer and BioNTech sent stocks soaring as investors s…

Healthcare stocks led the market higher on Wednesday as major indexes flirted with postelection rec…

The FDA has extended its deadline to approve or reject Biogen's drug by three months. Analysts say …

These are Business Insider's biggest healthcare stories for November 9.

These are the top stories written by Business Insider's healthcare team for the week ending Novembe…

These are Business Insider's biggest healthcare stories for November 5.

These are Insider's biggest healthcare stories for June 9.

Buffett's lieutenants may have trimmed their stake in Apple for a few reasons. They may have wanted…

Specifically, Goldman Sachs selected names names with a market capitalization greater than $10 bill…

The positive news follows a drop of about 35% in the shares' value over the last 12 months, represe…

A spokesperson for Allergan said the company "does not comment on market rumor or speculation." Mer…

Buffett's Berkshire Hathaway conglomerate shelled out $549 million for a 2.4% stake in US supermark…

The growth rate of weekly COVID-19 cases is currently at its slowest since mid-March, according to …

"This disappointing news confirms the complexity of treating Alzheimer's disease and the need to fu…

Markets gave up gains late in the trading day after getting an early boost when the Labor Departmen…

"These BAN2401 18-month data offer important insights in the investigation of potential treatment o…